AI-Driven Peptide Discovery: Machine learning algorithms can now predict peptide sequences with desired receptor affinity and metabolic stability, dramatically accelerating the drug discovery pipeline
More than half of participants had type 2 diabetes and approximately three-quarters were living with obesity
Future studies are needed to compare the clinical impact of GLP-1RA, in terms of NNT, with other therapies in the pipeline that target the various pathways in the ASCVD process, such as bempedoic acid which has been associated with reduced risk of MI and coronary revascularization due to the improvement in lipid and inflammatory profiles [77]
In terms of growth trends, the demand for 'Short-acting' GLP-1 drugs is rising due to increasing awareness and preference for personalized treatment approaches, alongside substantial investment in clinical trials exploring their efficacy in broader patient populations
Additional studies suggest that l-carnitine promotes exercise recovery by moderating tissue damage, decreasing production of free radicals and reducing muscle soreness following exercise.* What Is The Source